§ COMPARE REGULATORS

Swissmedic vs NMPA: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of Swissmedic (Switzerland) vs NMPA (China).

Swissmedic

Swiss Agency for Therapeutic Products

Switzerland

Swissmedic regulates medical devices in Switzerland under the revised Medical Devices Ordinance (MedDO), which is largely aligned with EU MDR. Switzerland recognizes EU CE certificates for most device

CLASSES

Class I, IIa, IIb, III

PATHWAY

EU CE recognition / Swiss conformity assessment

KEY FUNCTIONS
  • MedDO compliance oversight
  • Recognition of EU CE certificates
  • Swiss market surveillance
  • MDSAP participation

NMPA

National Medical Products Administration (China)

China

China's NMPA regulates medical devices through CMDE (Center for Medical Device Evaluation) technical reviews. China uses a three-class risk-based system. Foreign manufacturers must appoint a Marketing

CLASSES

Class I, II, III

PATHWAY

NMPA Registration (CMDE review)

KEY FUNCTIONS
  • CMDE technical review
  • MAH (Marketing Authorization Holder) system
  • In-country testing requirements
  • Clinical trial oversight
  • NMPA registration certificates

MedFlux monitors both Swissmedic and NMPA in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS